The effect of low-dose inhalation of nitric oxide in patients with pulmonary fibrosis

European Respiratory Journal

Volumn 10, Issue 9, 1997, Pages 2051-2054

  Yoshida, M ^a   Taguchi, O ^a   Gabazza, E C ^a   Yasui, H ^a   Kobayashi, T ^a   Kobayashi, H ^a   Maruyama, K ^a   Adachi, Y ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Nitric oxide; Oxygen; Pulmonary fibrosis

Indexed keywords

NITRIC OXIDE; OXYGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROSIS; GAS EXCHANGE; HUMAN; INHALATION; INHALATIONAL DRUG ADMINISTRATION; LUNG HEMODYNAMICS; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADMINISTRATION, INHALATION; AGED; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; OXYGEN INHALATION THERAPY; PULMONARY CIRCULATION; PULMONARY FIBROSIS; PULMONARY GAS EXCHANGE; RESPIRATORY MECHANICS;

EID: 0030884931     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10092051     Document Type: Article

References (20)

1. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY. Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic and biochemical aspects. Ann Intern Med 1976; 85: 769-788.
2. Carrington CB, Gaensler EA, Coutu RE, FitzGerald MX, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978; 298: 801-809.
3. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980; 35: 171-180.
4. Strom K, Boe J, and the Swedish Society of Chest Medicine. Quality assessment and predictors of survival in long-term domiciliary oxygen therapy. Eur Respir J 1991; 4: 50-58.
5. Miyamoto K, Aida A, Nishimura M, Aiba M, Kira S, Kawakami Y, and the Respiratory Failure Research Group in Japan. Gender effect on prognosis of patients receiving long-term home oxygen therapy. Am J Respir Crit Care Med 1995; 152: 972-976.
6. Weitzenblum E, Ehrhart M, Rasaholinjanahary J, Hirth C. Pulmonary hemodynamics in idiopathic pulmonary fibrosis and other interstitial pulmonary diseases. Respiration 1983; 44: 118-127.
7. Harris P, Heath D. The pulmonary vasculature in fibrosis and granulomatous disease of the lung. In: Harris P, Heath D, eds. The Human Pulmonary Circulation. New York, Churchill Livingstone, 1986; pp. 612-623.
8. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83: 2038-2047.
9. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338: 1173-1174.
10. Roberts JD, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation 1993; 87: 447-453.
11. Adnot S, Kouyoumdjian C, Defouilloy C, et al. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am Rev Respir Dis 1993; 148: 310-316.
12. Moinard J, Manier G, Pillet O, Castang Y. Effect of inhaled nitric oxide on hemodynamics and V′A/Q′ inequalities in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 149: 1482-1487.
13. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328: 399-405.
14. Channick RN, Hoch RC, Newhart JW, Johnson FW, Smith CM. Improvement in pulmonary hypertension and hypoxemia during nitric oxide inhalation in a patient with end-stage pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149: 811-814.
15. Maruyama K, Kobayasi H, Taguchi O, Chikusa H, Muneyuki M. Higher doses of inhaled nitric oxide might be less effective in improving oxygenation in a patient with interstitial pulmonary fibrosis. Anesth Analg 1995; 81: 204-213.
16. Gerlach H, Rossaint R, Pappert D, Falke KJ. Time course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993; 23: 499-502.
17. Yoshida M, Taguchi O, Gabazza EC, et al. Combined inhalation of nitric oxide and oxygen in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155: 526-529.
18. Barbera JA, Roger N, Roca J, Rovira I, Higenbottam TW, Rodriguez-Roisin R. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet 1996; 347: 436-440.
19. Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Pelletier A. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985; 131: 493-498.
20. Kouyoumdjian C, Adnot S, Levame M, Eddahibi S, Bousbaa H, Raffestin B. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest 1994; 94: 578-584.